Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation - TechCrunch

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy …